Prepaid product supply Contract With Customer, Liability, Revenue Invoiced As Prepayments For Product Supply, Current Contract With Customer, Liability, Revenue Invoiced As Prepayments For Product Supply, Current Award Timing Predetermined Award Timing Predetermined [Flag] Remainder of 2025 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Asset Class [Axis] Asset Class [Axis] Entity File Number Entity File Number Additional Paid-In Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Schedule of Additional Details of Leases Schedule Of Additional Details Of Leases [Table Text Block] The tabular disclosure of additional details of the leases. Leases [Abstract] Leases [Abstract] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Purchases of investments Payments to Acquire Short-Term Investments Accounts payable Increase (Decrease) in Accounts Payable Secured Overnight Financing Rate (SOFR) Secured Overnight Financing Rate (SOFR) [Member] Licensing revenue License License [Member] Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] XPHOZAH Product, XPHOZAH [Member] Product, XPHOZAH Net loss per share of common stock - basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Commercial paper Commercial Paper [Member] Inventory Inventory Inventory, Gross REVENUE Revenue from Contract with Customer [Text Block] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Schedule of Information Regarding Operating Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Inventory Disclosure [Abstract] Issuance of common stock upon vesting of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Issuance of common stock under employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Schedule of Securities Classified as Cash, Cash Equivalents and Short-Term Investments Cash, Cash Equivalent, and Investment [Table Text Block] Adjustment to Compensation, Amount Adjustment to Compensation Amount Product sales, net as a percentage of total revenues Concentration risk (as percent) Concentration Risk, Percentage Unamortized discount and debt issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Schedule of Noncurrent Inventory Schedule of Inventory, Noncurrent [Table Text Block] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Copay Assistance and Returns Contract With Customer, Copay and Returns [Member] Contract With Customer, Copay and Returns Stock option grants Options to purchase common stock Share-Based Payment Arrangement, Option [Member] U.S. government-sponsored agency bonds US Government Corporations and Agencies Securities [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS Cash, Cash Equivalent, and Short-Term Investment [Text Block] Non-cash royalty revenue related to the sale of future royalties Non-Cash Royalty Related To Sale Of Future Royalties Non-Cash Royalty Related To Sale Of Future Royalties Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Measurement Frequency [Axis] Measurement Frequency [Axis] Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Insider Trading Policies and Procedures [Line Items] Stock-based compensation expense Share-Based Payment Arrangement, Expense Common stock, shares authorized (in shares) Common Stock, Shares Authorized Issuance of common stock in at-the-market offering (in shares) Stock Issued During Period, Shares, New Issues Current assets Assets, Current [Abstract] Options forfeited or canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity Liabilities and Equity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Recurring Fair Value, Recurring [Member] Number of Shares (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Cover [Abstract] Cover [Abstract] Options exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Royalty payments and commercial milestone payments Increase (Decrease) in Royalties Payable Beginning balance Ending balance Contract With Customer, Gross To Net Sales Accruals Contract With Customer, Gross To Net Sales Accruals Schedule of Undiscounted Cash Payment Obligations for Operating Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Kyowa Kirin Kyowa Kirin Co. Ltd [Member] Represents the information pertaining to Kyowa Kirin Co., Ltd. Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument [Line Items] Debt Instrument [Line Items] Laura Williams [Member] Laura Williams Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Total operating lease liabilities Operating Lease, Liability U.S. government-sponsored agency bonds US Government Agencies Debt Securities [Member] Adjustments to principal value Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Issuance of common stock for services (in shares) Stock Issued During Period, Shares, Issued for Services Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Deferred revenue Increase (Decrease) in Deferred Revenue Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Name Measure Name Schedule of Stock-Based Compensation Expense Recognized Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Thereafter Lessee, Operating Lease, Liability, To Be Paid, After Year Four Lessee, Operating Lease, Liability, To Be Paid, After Year Four Current portion of operating lease liability Current portion of lease liabilities Less: Current portion of operating lease liability Operating Lease, Liability, Current Closing fee Debt Instrument, Closing Fee Amount Debt Instrument, Closing Fee Amount Document Fiscal Period Focus Document Fiscal Period Focus Total cash, cash equivalents and investments, Gross Unrealized Losses Cash Cash Equivalents And Investments Gross Unrealized Losses Cash, cash equivalents and investments gross unrealized losses. Award Timing Method Award Timing Method [Text Block] Litigation Case [Domain] Litigation Case [Domain] Award Type [Axis] Award Type [Axis] Deferred revenue, non-current Beginning balance Ending balance Contract with Customer, Liability, Noncurrent Total long-term debt Long-Term Debt Total assets Assets Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Schedule of Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Trading Symbol Trading Symbol 2029 Lessee, Operating Lease, Liability, to be Paid, Year Four Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Accrued expenses and other current liabilities Accrued Liabilities and Other Liabilities Entity Address, City or Town Entity Address, City or Town Cardinal Health Cardinal Health [Member] Cardinal Health Operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Product supply delivered Contract With Customer, Liability, Revenue Recognized Cash Not Received, Current Contract With Customer, Liability, Revenue Recognized Cash Not Received, Current Other segment expenses Segment Reporting, Other Segment Item, Amount Concentration Risk Type [Axis] Concentration Risk Type [Axis] INVENTORY Inventory Disclosure [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount RSU grants Restricted stock units Restricted Stock Units (RSUs) [Member] Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Assets Assets, Fair Value Disclosure [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Right-of-use assets obtained in exchange for lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Lease costs Lease, Cost [Abstract] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Options outstanding balance, beginning (in shares) Options outstanding balance, ending (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Facility fee Debt Issuance Costs, Net Level 2 Fair Value, Inputs, Level 2 [Member] Gross To Net Sales Accrual And Reserve Classification [Axis] Gross To Net Sales Accrual And Reserve Classification [Axis] Gross To Net Sales Accrual And Reserve Classification IBSRELA Product, IBSRELA [Member] Product, IBSRELA Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Accreted value of final fee Debt Instrument, Fee Amount Undiscounted cash payment obligations Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Plan Name [Axis] Plan Name [Axis] Purchase price (in dollars per share) Share Based Compensation Arrangement by Share Based Payment Award, Purchased Price of Share Represents the purchase price per share of shares issued to employees under the plan. Number of new loans Debt Instrument, Number Of New Loans Debt Instrument, Number Of New Loans PEO PEO [Member] Proceeds from 2022 Loan Agreement, net of costs Proceeds from Issuance of Secured Debt Schedule of Revenue Disaggregation of Revenue [Table Text Block] Changes in operating assets and liabilities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Issuance of common stock upon exercise of options Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Number of RSUs (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Provision for income taxes Income Tax Expense (Benefit) Floating per annum rate (as percent) Debt Instrument, Basis Spread on Variable Rate Sale of Stock [Domain] Sale of Stock [Domain] Gross To Net Sales Accrual And Reserve Classification [Domain] Gross To Net Sales Accrual And Reserve Classification [Domain] Gross To Net Sales Accrual And Reserve Classification [Domain] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Products and Services [Domain] Product and Service [Domain] Customer Customer Concentration Risk [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] 2022 Term Loan Term Loan 2022 [Member] Term Loan 2022 Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Non-cash lease expense Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-vested restricted stock units, beginning balance (in shares) Non-vested restricted stock units, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Deferred Revenue Balances Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] General and administrative expenses General and Administrative Expense Investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Gross product revenue Revenue, Product and Service Benchmark [Member] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Selling, general and administrative Selling, General and Administrative Expenses [Member] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Schedule of Lease Costs Lease, Cost [Table Text Block] Prepaid commercial manufacturing Prepaid Commercial Manufacturing, Current Prepaid Commercial Manufacturing, Current PEO Total Compensation Amount PEO Total Compensation Amount Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Money market funds Money market funds Money Market Funds [Member] Equity Components [Axis] Equity Components [Axis] Issuance of common stock for services Stock Issued During Period, Value, Issued for Services Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Total cash, cash equivalents and investments Investments and Cash Product sales, net Product [Member] Number of reportable segments Number of Reportable Segments NATURE OF OPERATIONS Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Supplementary disclosure of cash flow information Supplemental Cash Flow Information [Abstract] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Other Performance Measure, Amount Other Performance Measure, Amount Weighted-Average Exercise Price per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Entity Address, State or Province Entity Address, State or Province Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Prepaid product supply Contract With Customer, Liability, Revenue Invoiced As Prepayments For Product Supply, Noncurrent Contract With Customer, Liability, Revenue Invoiced As Prepayments For Product Supply, Noncurrent Total current liabilities Liabilities, Current Individual: Individual [Axis] Research and development Research and Development Expense [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Net cash provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] 2023 Open Market Sales Agreement Open Market Sales Agreement 2023, At The Market Offering [Member] Open Market Sales Agreement 2023, At The Market Offering Right-of-use assets Right-of-use assets Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Entity Interactive Data Current Entity Interactive Data Current Operating lease expense Operating Lease, Cost Plan Name [Domain] Plan Name [Domain] Average Remaining Vesting Period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Issuance of common stock upon exercise of options (in shares) Options exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Fosun Pharma Shanghai Fosun Pharmaceutical Industrial Development [Member] Represents Shanghai Fosun Pharmaceutical Industrial Development. Reclassify amounts to be recognized in the next twelve months Contract With Customer, Liability, Revenue To Be Recognized In Next Twelve Months Contract With Customer, Liability, Revenue To Be Recognized In Next Twelve Months Less Segment Reconciliation [Abstract] SEGMENT REPORTING Segment Reporting Disclosure [Text Block] U.S. treasury securities US Treasury Notes Securities [Member] Knight Agreement License Agreement Development Commercialization Distribution In Canada [Member] Agreement for the development, commercialization and distribution fo tenapanor in Canada. The Knight Agreement. Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] U.S. treasury securities US Treasury Securities [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Selling, general and administrative Selling, General and Administrative Expense Depreciation and amortization expense Depreciation, Depletion and Amortization Schedule of Total Unrecognized Stock-Based Compensation Expense, Net of Estimated Forfeitures Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block] Other assets Other Assets, Noncurrent Customer [Domain] Customer [Domain] Entity Central Index Key Entity Central Index Key PEO Name PEO Name Cost of goods sold Cost of Product and Service Sold [Abstract] ESPP ESPP shares issuable Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Finished goods Inventory, Finished Goods, Gross Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Weighted-average sales price per share (in dollars per share) Sale Of Stock, Weighted-Average Price Per Share Sale Of Stock, Weighted-Average Price Per Share Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Deferred revenue Beginning balance Ending balance Contract with Customer, Liability, Current Segments [Axis] Segments [Axis] AZ Termination Agreement AstraZeneca Termination Agreement [Member] AstraZeneca Termination Agreement Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Additional details Lessee, Operating Lease, Description [Abstract] Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Class of Stock [Domain] Class of Stock [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Other, net Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item EQUITY INCENTIVE PLANS​ Share-Based Payment Arrangement [Text Block] Reportable Segment Reportable Segment [Member] Reportable Segment Assets Assets [Abstract] Inventory, non-current Inventory, non-current Inventory, Noncurrent Underlying Security Market Price Change Underlying Security Market Price Change, Percent Debt Instrument [Axis] Debt Instrument [Axis] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Stockholders’ equity Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Research and development Research and Development Expense Accumulated Other Comprehensive Income/(Loss) AOCI Attributable to Parent [Member] Interest rate (as percent) Debt Instrument, Interest Rate, Stated Percentage Deferred Royalty Obligation [Roll Forward] Deferred Royalty Obligation [Roll Forward] Deferred Royalty Obligation Short-term investments Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract] Operating lease liability, net of current portion Operating lease liability, net of current portion Operating Lease, Liability, Noncurrent Issuance of common stock for services Stock Issued Work in process Inventory, Work in Process, Gross Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Product supply revenue Product Supply Revenue [Member] Product Supply Revenue Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Schedule of Long-Term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Title of Individual [Domain] Title and Position [Domain] Total operating expenses Costs and Expenses Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Unrecognized Compensation Expense (in thousands) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Commission on sale of stock per agreement (as percent) Stock Issuance Cost, Commission, Percent Stock Issuance Cost, Commission, Percent Document Quarterly Report Document Quarterly Report Assets, fair value Assets, Fair Value Disclosure Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two Number of segments Number of Operating Segments Term Loan F Term Loan 2022 F [Member] Term Loan 2022 F Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Restatement Determination Date: Restatement Determination Date [Axis] Final fee due upon maturity, acceleration, prepayment, or termination (as percent) Debt Instrument, Fee Due Upon Maturity, Acceleration, Prepayment, Termination, Percentage Debt Instrument, Fee Due Upon Maturity, Acceleration, Prepayment, Termination, Percentage AstraZeneca Astrazeneca [Member] Represents information pertaining to AstraZeneca. Non-PEO NEO Non-PEO NEO [Member] Issuance of common stock under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Sale of Stock [Axis] Sale of Stock [Axis] Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] 2026 Lessee, Operating Lease, Liability, to be Paid, Year One Allocated facilities, information technology, and human resources Allocated Facilities, Information Technology, And Human Resources Costs Allocated Facilities, Information Technology, And Human Resources Costs Equity Awards Adjustments Equity Awards Adjustments [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Term loan face amount Debt Instrument, Face Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Accrued compensation and benefits Increase (Decrease) in Employee Related Liabilities MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Fosun Agreement License Agreement Development Commercialization Distribution In China [Member] Agreement for the development, commercialization and distribution of tenapanor in China. The Fosun Agreement. Non-vested restricted stock units, beginning balance (in dollars per share) Non-vested restricted stock units, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Non-Current Change In Contract With Customer Liability, Noncurrent, Rollforward [Roll Forward] Change In Contract With Customer Liability, Noncurrent, Rollforward Schedule of Chargebacks, Discounts and Reserve Balances Schedule Of Gross To Net Sales Accruals [Table Text Block] Schedule Of Gross To Net Sales Accruals Denominator Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Term A Loan Term Loan 2022 A [Member] Term Loan 2022 A Revenues Revenues [Abstract] 2017 KKC Agreement License Agreement Development Commercialization Distribution In Japan [Member] Agreement for the development, commercialization and distribution of tenapanor in Japan. The 2017 KKC Agreement. Investment in continuous unrealized loss position for more than one year Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Accumulated other comprehensive (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Other reconciliation items Segment Reporting, Other Reconciling Item, Amount Segment Reporting, Other Reconciling Item, Amount Financial Instruments [Domain] Financial Instruments [Domain] Unrealized losses on available-for-sale securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Litigation Case [Axis] Litigation Case [Axis] Segments [Domain] Segments [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Commercial paper Commercial Paper, Not Included with Cash and Cash Equivalents [Member] Inventory Increase (Decrease) in Inventories Total Inventory, Net Less: Current portion of long-term debt Loans Payable, Current Advance Royalties [Abstract] Company Selected Measure Name Company Selected Measure Name DEFERRED ROYALTY OBLIGATION RELATED TO THE SALE OF FUTURE ROYALTIES Asset Retirement Obligation Disclosure [Text Block] BORROWING Debt Disclosure [Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Cash paid for operating leases Operating Lease, Payments Proceeds from ESPP Proceeds from Stock Plans Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Common stock, $0.0001 par value; 500,000,000 shares authorized; 240,765,516 and 238,015,825 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively Common Stock, Value, Issued COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Title of Individual [Axis] Title and Position [Axis] Shares used in computing net loss per share - diluted (in shares) Weighted average common shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Provisions Contract With Customer, Gross To Net Sales, Provisions Contract With Customer, Gross To Net Sales, Provisions Loan Agreement Loans Payable [Member] Entity Small Business Entity Small Business Document Transition Report Document Transition Report Schedule of Revenue from Customers as a Percentage of Total Product Revenue, Net Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Underlying Securities Award Underlying Securities Amount Equity Component [Domain] Equity Component [Domain] Healthcare royalty partners IV, L.P HealthCare Royalty Partners IV, L.P [Member] HealthCare Royalty Partners IV, L.P Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Common stock Common Class A [Member] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Revenue from Contract with Customer [Abstract] Rebates, Wholesaler and GPO Fees Contract With Customer, Rebates, Wholesaler And GPO Fees [Member] Contract With Customer, Rebates, Wholesaler And GPO Fees Operating lease liabilities Increase (Decrease) in Operating Lease Liability Non-cash interest expense Amortization of Debt Discount (Premium) Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] Cash and cash equivalents Cash and Cash Equivalent [Abstract] NET LOSS PER SHARE Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Loss Contingencies [Table] Loss Contingencies [Table] Product and Service [Axis] Product and Service [Axis] Gross proceeds Proceeds from Issuance of Common Stock Total revenues Revenue Revenue from Contract with Customer, Excluding Assessed Tax All Individuals All Individuals [Member] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Name Forgone Recovery, Individual Name Total current assets Assets, Current Right-of-use assets and lease liabilities Assets and Liabilities, Lessee [Abstract] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Knight Knight Therapeutics Inc [Member] Represents information pertaining to Knight Therapeutics Inc. Proceeds from issuance of common stock under equity incentive and stock purchase plans Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised Number of lawsuits Loss Contingency, New Claims Filed, Number Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] BioRidge Pharma, LLC BioRidge Pharma, LLC [Member] BioRidge Pharma, LLC Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current liabilities Liabilities, Current [Abstract] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Level 1 Fair Value, Inputs, Level 1 [Member] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Stock-based Compensation [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Collaboration and Licensing Agreements Collaboration and Licensing Agreements n/a Accrued and other liabilities Increase (Decrease) in Accrued Liabilities Net loss per share of common stock - diluted (in dollars per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Title of 12(b) Security Title of 12(b) Security Supplementary disclosure of non-cash activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Loan agreement, covenant, sum of net product revenue and unrestricted cash as percentage of outstanding loan balance, calculation period (in months) Loan Agreement, Covenant, Sum Of Net Product Revenue And Unrestricted Cash As Percentage Of Outstanding Loan Balance, Calculation Period Loan Agreement, Covenant, Sum Of Net Product Revenue And Unrestricted Cash As Percentage Of Outstanding Loan Balance, Calculation Period Royalty distributed to HCR Increase (Decrease) To Deferred Royalty Obligation, Royalty Distributed Increase (Decrease) To Deferred Royalty Obligation, Royalty Distributed Current Change In Contract With Customer Liability, Current, Rollforward [Roll Forward] Change In Contract With Customer Liability, Current, Rollforward Earnings Per Share [Abstract] Earnings Per Share [Abstract] Other income, net Nonoperating Income (Expense) Prepaid commercial manufacturing, non-current Prepaid Commercial Manufacturing, Non Current Prepaid Commercial Manufacturing, Non Current Floor Rate Secured Overnight Financing Rate (SOFR) Floor Rate [Member] Secured Overnight Financing Rate (SOFR) Floor Rate Schedule of Anti-Dilutive Securities Not Considered in Diluted Net Loss Per Common Share Calculation Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Deferred royalty obligation related to the sale of future royalties Deferred royalty obligation balance as of January 1, Deferred royalty obligation balance as of June 30, Deferred Royalty Obligation, Noncurrent Deferred Royalty Obligation, Noncurrent Short-term investments Debt Securities, Available-for-Sale, Current Discounts and Chargebacks Contract With Customer, Discounts And Chargebacks [Member] Contract With Customer, Discounts And Chargebacks Stock-based compensation Share-Based Payment Arrangement, Expense, Adjusted Share-Based Payment Arrangement, Expense, Adjusted Term C Loan Term Loan 2022 C [Member] Term Loan 2022 C Imputed interest expenses Lessee, Operating Lease, Liability, Undiscounted Excess Amount Reclassify amounts to be recognized in the next twelve months Contract With Customer, Liability, Decrease In Revenue, To Be Recognized In Next Twelve Months Contract With Customer, Liability, Decrease In Revenue, To Be Recognized In Next Twelve Months Number of defendants Loss Contingency, Number of Defendants Cash paid for income taxes Income Taxes Paid, Net Options exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Product supply delivered Contract With Customer, Liability, Revenue Recognized Cash Not Received, Noncurrent Contract With Customer, Liability, Revenue Recognized Cash Not Received, Noncurrent Maximum potential payment per agreement Collaborative Arrangement, Potential Payment Per Termination Agreement, Maximum Collaborative Arrangement, Potential Payment Per Termination Agreement, Maximum Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Award Timing Disclosures [Line Items] Schedule of Current Inventory Schedule of Inventory, Current [Table Text Block] Total principal Long-Term Debt, Gross Options granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Measurement Frequency [Domain] Measurement Frequency [Domain] Accrued compensation and benefits Employee-related Liabilities, Current Total undiscounted operating lease payments Lessee, Operating Lease, Liability, to be Paid STOCKHOLDERS’ EQUITY Equity [Text Block] Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Expiration Date Trading Arrangement Expiration Date Yankee bonds Debt Security, Government, Non-US [Member] Unrealized losses on available-for-sale securities Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Numerator Net Income (Loss) Attributable to Parent [Abstract] Adoption Date Trading Arrangement Adoption Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Entity Current Reporting Status Entity Current Reporting Status Credits/payments Contract With Customer, Gross To Credits Or Deductions Issued Contract With Customer, Gross To Credits Or Deductions Issued Customer [Axis] Customer [Axis] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Loss from operations Operating Income (Loss) Accumulated deficit Retained Earnings (Accumulated Deficit) Total cash, cash equivalents and investments, Gross Unrealized Gains Cash Cash Equivalents And Investments Gross Unrealized Gains Cash, cash equivalents and investments gross unrealized gains. Financial Instrument [Axis] Financial Instrument [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Research and development Research And Development Expense, Adjusted Research And Development Expense, Adjusted Effective interest rate Contract With Customer, Liability, Amortization, Effective Interest Rate, Percent Contract With Customer, Liability, Amortization, Effective Interest Rate, Percent Prepaid commercial manufacturing Prepaid Commercial Manufacturing Prepaid Commercial Manufacturing Prepaid commercial manufacturing Increase (Decrease) In Prepaid Commercial Manufacturing Expense Increase (Decrease) In Prepaid Commercial Manufacturing Expense Class of Stock [Axis] Class of Stock [Axis] Current Fiscal Year End Date Current Fiscal Year End Date Total future payment obligation Long-Term Debt, Excluding Interest Payments Long-Term Debt, Excluding Interest Payments Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Term B Loan Term Loan 2022 B [Member] Term Loan 2022 B Non-cash interest expense related to sale of future royalties Increase (Decrease) To Deferred Royalty Obligation, Non-Cash Interest Expense Related To Sale Of Future Royalties Increase (Decrease) To Deferred Royalty Obligation, Non-Cash Interest Expense Related To Sale Of Future Royalties Weighted-Average Grant Date Fair Value per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Statement [Table] Statement [Table] Non-cash royalty revenue related to the sale of future royalties Non-Cash Royalty Related To Sale of Future Royalties [Member] Non-Cash Royalty Related To Sale of Future Royalties Adjustments to reconcile net loss to net cash used in operating activities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] COLLABORATION AND LICENSING AGREEMENTS Collaborative Arrangement Disclosure [Text Block] Financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash Cash [Member] Long-term debt Loans Payable, Noncurrent Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Variable Rate [Domain] Variable Rate [Domain] Term Loan 2022 F And G Term Loan 2022 F And G [Member] Term Loan 2022 F And G Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount All Adjustments to Compensation All Adjustments to Compensation [Member] Total cash, cash equivalents and investments, Amortized Cost Investments And Cash, Amortized Cost Investments And Cash, Amortized Cost Amendment Flag Amendment Flag McKesson Corporation McKesson Corporation [Member] McKesson Corporation LEASES Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Go v. Raab Go Versus Raab [Member] Go Versus Raab Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule Of Deferred Royalty Obligation Schedule Of Deferred Royalty Obligation [Table Text Block] Schedule Of Deferred Royalty Obligation Cencora (formerly AmerisourceBergen Drug Corporation) Cencora [Member] Cencora Selling expenses Selling Expense Schedule of Fair Value of Financial Assets Measured on a Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Shares used in computing net loss per share - basic (in shares) Weighted average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Total cost of goods sold Cost of Product and Service Sold Schedule of Computation of Net Loss Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Board of directors Director [Member] Options exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Segment Reporting [Abstract] Cost of revenue Cost of Revenue Gross-to-net sales accruals and reserves Contract With Customer, Gross To Net Sales Accrual [Roll Forward] Contract With Customer, Gross To Net Sales Accrual Reported as Inventory, Gross [Abstract] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Entity Tax Identification Number Entity Tax Identification Number Options outstanding balance, beginning (in dollars per share) Options outstanding balance, ending (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Term Loan G Term Loan 2022 G [Member] Term Loan 2022 G Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Term D Loan Term Loan 2022 D [Member] Term Loan 2022 D Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common Stock, Shares, Issued Weighted-average remaining term (in years) Operating Lease, Weighted Average Remaining Lease Term Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Use of Estimates Use of Estimates, Policy [Policy Text Block] Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Contingencies [Line Items] Loss Contingencies [Line Items] Loan agreement covenant, sum of net product revenue and unrestricted cash as percentage of outstanding loan balance, minimum Loan Agreement, Covenant, Sum of Net Product Revenue and Unrestricted Cash As Percentage Of Outstanding Loan Balance, Minimum Loan Agreement, Covenant, Sum Of Net Product Revenue And Unrestricted Cash As Percentage Of Outstanding Loan Balance, Minimum Insider Trading Arrangements [Line Items] Non-cash interest expense related to the sale of future royalties Non-Cash Interest Expense Related To Sale Of Royalties Non-Cash Interest Expense Related To Sale Of Royalties Security Exchange Name Security Exchange Name Options forfeited or canceled (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Raw materials Inventory, Raw Materials, Gross Other cost of revenue Product and Service, Other [Member] Total liabilities Liabilities Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Product Concentration Risk Product Concentration Risk [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Term Loan E Term Loan 2022 E [Member] Term Loan 2022 E Proceeds from maturities and redemptions of investments Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Operating expenses Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Asset Class [Domain] Asset Class [Domain] Ardelyx, Inc. Stockholder Derivative Litigation Ardelyx, Inc. Stockholder Derivative Litigation [Member] Ardelyx, Inc. Stockholder Derivative Litigation Statement [Line Items] Statement [Line Items] Asset-backed securities Asset-backed securities Asset-Backed Securities [Member] Variable Rate [Axis] Variable Rate [Axis] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Fair Value Cash and Cash Equivalent Counterparty Name [Axis] Counterparty Name [Axis] Common Stock Common Stock [Member] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Fair Value Debt Securities, Available-for-Sale Maximum aggregate offering price Maximum Aggregate Offering Price Amount of maximum aggregate offering price. Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Corporate bonds Corporate Debt Securities [Member] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Net increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation